Blogging requires time, energy and effort. Ask anyone to tell a story about science and medicine in 300-500 words that captures your attention, and they will tell you it is not easy.
In a world where so much of what constitutes science news is a rehash of press releases, generating original blog content is something that our pharma & biotech consultants do by night, while working by day (or is it the other way round?).
Both Biotech Strategy Blog and Pharma Strategy Blog are part of the Research Blogging network (ResearchBlogging.org), that allows a link back to original scientific papers using the digital object identifier (DOI) reference that journals now publish. As a company focused on bringing new to products to market, we believe that scientific data is the key to commercial success.
Pieter Droppert recently received an “Editor’s Selection” from ResearchBlogging.org for his post on “Regenerative Medicine – can we rebuild our bodies as we get older?” Recognition is always appreciated. Many thanks to Dr Peter Janiszewski for that.